Article By:
The Life Sciences Report
Friday, August 29, 2014 5:36 AM EDT
Former biotech consultant Yale Jen picked up a few tricks advising companies on their pipelines before he came to Wall Street as a sellside analyst.
In this article: GSK, PFE, ISIS, RPRX, BIIB, MSTX, ADMA, GLYC
